CO5690602A2 - Regimenes anticonceptivos trifasicos extendidos - Google Patents

Regimenes anticonceptivos trifasicos extendidos

Info

Publication number
CO5690602A2
CO5690602A2 CO06037928A CO06037928A CO5690602A2 CO 5690602 A2 CO5690602 A2 CO 5690602A2 CO 06037928 A CO06037928 A CO 06037928A CO 06037928 A CO06037928 A CO 06037928A CO 5690602 A2 CO5690602 A2 CO 5690602A2
Authority
CO
Colombia
Prior art keywords
progestin
estrogen
anticonceptive
regimes
extended
Prior art date
Application number
CO06037928A
Other languages
English (en)
Inventor
Katherine D Laguardia
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CO5690602A2 publication Critical patent/CO5690602A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

1.- Un método de anticoncepción que comprende los pasos de: administrar a una mujer de edad fértil una combinación de un estrógeno y una progestina durante al menos 42 días consecutivos seguido de un período libre de hormonas de 4 a 8 días, dicho estrógeno y progestina son administrados en una dosificación diaria anticonceptivamente efectiva durante una secuencia de por lo menos dos ciclos de al menos 21 días, en donde la dosificación de estrógeno permanece constante durante cada ciclo y la dosificación de progestina incrementa en las tres fases durante cada ciclo.
CO06037928A 2003-10-01 2006-04-21 Regimenes anticonceptivos trifasicos extendidos CO5690602A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50753603P 2003-10-01 2003-10-01

Publications (1)

Publication Number Publication Date
CO5690602A2 true CO5690602A2 (es) 2006-10-31

Family

ID=34421627

Family Applications (1)

Application Number Title Priority Date Filing Date
CO06037928A CO5690602A2 (es) 2003-10-01 2006-04-21 Regimenes anticonceptivos trifasicos extendidos

Country Status (14)

Country Link
US (1) US20050090475A1 (es)
EP (1) EP1673094A1 (es)
JP (1) JP2007507534A (es)
KR (1) KR20060129175A (es)
CN (1) CN1863537A (es)
AU (1) AU2004277998A1 (es)
BR (1) BRPI0414945A (es)
CA (1) CA2540697A1 (es)
CO (1) CO5690602A2 (es)
NO (1) NO20061937L (es)
NZ (1) NZ545969A (es)
RU (1) RU2006114791A (es)
WO (1) WO2005032558A1 (es)
ZA (1) ZA200603416B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
AU2004257772B2 (en) 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AR051931A1 (es) * 2004-10-07 2007-02-21 Duramed Pharmaceuticals Inc Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36247A (en) * 1862-08-19 Improvement in car-couplings
US4264575A (en) * 1979-07-16 1981-04-28 Eli Lilly And Company Contraceptive methods and compositions
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
DE3929376C1 (es) * 1989-09-05 1991-04-18 E.I. Du Pont De Nemours And Co., Wilmington, Del., Us
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) * 1996-07-26 2002-11-12 Wyeth Oral contraceptive
DE19705229C2 (de) * 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DK1007052T3 (da) * 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6326392B1 (en) * 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US20020177580A1 (en) * 2001-05-23 2002-11-28 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
US20030018018A1 (en) * 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea

Also Published As

Publication number Publication date
JP2007507534A (ja) 2007-03-29
EP1673094A1 (en) 2006-06-28
NO20061937L (no) 2006-06-29
ZA200603416B (en) 2007-09-26
CA2540697A1 (en) 2005-04-14
BRPI0414945A (pt) 2006-11-07
RU2006114791A (ru) 2007-11-27
KR20060129175A (ko) 2006-12-15
WO2005032558A1 (en) 2005-04-14
NZ545969A (en) 2008-07-31
AU2004277998A1 (en) 2005-04-14
CN1863537A (zh) 2006-11-15
US20050090475A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
CO5690602A2 (es) Regimenes anticonceptivos trifasicos extendidos
AR028809A1 (es) Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica
AR051931A1 (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes
AR030737A1 (es) Metodo de anticoncepcion y forma de administracion del mismo
AR024566A1 (es) Administracion de esteroides androgenicos no orales a mujeres
EA200201000A1 (ru) Гормон-заместительная терапия
NO986104L (no) Progesteron-anti-progesteron regimer
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
AR048722A1 (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos
ATE410171T1 (de) Graduierte östrogen-kontrazeptiva
TR200100234T2 (tr) Biyojen estrojensülfamatların hormon sübstitüsyon terapisinde kullanılması.
ECSP056009A (es) Regimenes contraceptivos transdermicos extendidos
PT1293210E (pt) Dispositivo e metodo anticoncepcional hormonal
CY1106374T1 (el) Μεθοδος θepαπειας αντικαταστασης ορμονης και μορφη χορηγησης της
CY1111406T1 (el) Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
AR021623A1 (es) Auxiliares acuosos para dar forma al cabello
AR039227A1 (es) Terapia de reemplazo hormonal
DK1937274T3 (da) Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception
AR039228A1 (es) Terapia de reemplazo hormonal
NO20072687L (no) Farmasoytisk prevensjonspreparat
AR039477A1 (es) Terapia de reemplazo hormonal
RU2001131730A (ru) Применение антипрогестогенов в комбинированной терапии

Legal Events

Date Code Title Description
FC Application refused